healthy, no evidence of disease
Showing 1 - 25 of >10,000
Colorectal Cancer, Healthy, no Evidence of Disease Trial in Buffalo, New York (behavioral intervention)
Completed
- Colorectal Cancer
- Healthy, no Evidence of Disease
- behavioral intervention
-
Buffalo, New York
- +1 more
Jul 20, 2022
Hepatobiliary Tumors Tissue Samples Acquisition
Recruiting
- Hepatocellular Carcinoma
- +7 more
- Gene expression analysis
- +10 more
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences & Peking Union Medical Colle
Jun 8, 2022
Healthy, no Evidence of Disease, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Los Angeles (light-scattering
Terminated
- Healthy, no Evidence of Disease
- +4 more
- light-scattering spectroscopy
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Nov 11, 2021
Cardiovascular Diseases Trial in Glasgow (Rapeseed oil, Sunflower oil)
Completed
- Cardiovascular Diseases
- Rapeseed oil
- Sunflower oil
-
Glasgow, Scotland, United KingdomUniversity of Glasgow
Apr 27, 2021
Metastatic Colorectal Cancer, No Evidence of Disease Status, ctDNA Monitoring Trial in Shanghai (ctDNA and adjuvant therapy,
Recruiting
- Metastatic Colorectal Cancer
- +2 more
- ctDNA and adjuvant therapy
- ctDNA
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 22, 2022
Unconscious Processing in Decision-making
Recruiting
- Healthy Volunteers
- No intervention
-
Pavia, Ita, ItalyIstituti Clinici Scientifici Maugeri SpA
Mar 20, 2023
Metastatic Colorectal Cancer Trial (Anti-PD-1 Monoclonal Antibody + Capecitabine)
Not yet recruiting
- Metastatic Colorectal Cancer
- Tislelizumab + Capecitabine
- Best supportive care
- (no location specified)
Sep 22, 2022
Colorectal Cancer Stage IV, No Evidence of Disease State Trial in Genova (Durvalumab Injection for intravenous use 500 mg vial
Recruiting
- Colorectal Cancer Stage IV
- No Evidence of Disease State
- Durvalumab Injection for intravenous use 500 mg vial solution for infusion
- Regorafenib 30 mg capsules
-
Genova, Liguria, ItalyIRCCS Ospedale Policlinico San Martino
May 16, 2022
Alzheimer, Dementia, Sleep Disorder Trial (LOCK Sleep Program, No intervention (control period/baseline data collection))
Not yet recruiting
- Alzheimer Disease
- +3 more
- LOCK Sleep Program
- No intervention (control period/baseline data collection)
- (no location specified)
Apr 7, 2023
Squamous Cell Carcinoma Trial in New York (Standard surveillance, Telemedicine surveillance (tele-surveillance), Questionnaires)
Recruiting
- Squamous Cell Carcinoma
- Standard surveillance
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 17, 2022
Microvascular Coronary Dysfunction Trial in Los Angeles (Handgrip, Altitude simulation, Leg exercise)
Recruiting
- Microvascular Coronary Dysfunction
- Handgrip
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Aug 17, 2021
Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)
Not yet recruiting
- Breast Cancer, Early Breast Cancer
- Camizestrant
- +5 more
- (no location specified)
Jul 11, 2023
Real World Evidence of Benralizumab in Eosinophilic Severe
Recruiting
- Severe Eosinophilic Asthma
-
Moscow, Russian FederationCity clinical hospital No57
Aug 8, 2022
Healthy, no Evidence of Disease, Obesity Trial in Chicago (behavioral dietary intervention, telephone-based intervention,
Terminated
- Healthy, no Evidence of Disease
- Obesity
- behavioral dietary intervention
- +2 more
-
Chicago, IllinoisNorthwestern University
Aug 27, 2020
Gut Permeability-related Inflammation and Cardiovascular Disease
Recruiting
- Obesity
- No experimental intervention will take place - the study is cross-sectional. Each participant will provide biological samples.
-
Stillwater, Oklahoma208 Nancy Randolph Davis, Oklahoma State University
Apr 8, 2022
Breast Tissue in Women Not Previously Diagnosed With Breast
Unknown status
- Breast Cancer
- Healthy, no Evidence of Disease
- Random fine need aspiration (rFNA)
- Mammogram
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Aug 28, 2020
(Proteomic and Genomic Analysis of Biospecimens)
Enrolling by invitation
- Oncology
- +8 more
- Observational Study Only. NO Intervention.
-
New Orleans, LouisianaAUD
Jun 2, 2023
SARS CoV 2 Infection Trial in Mexico City (Recombinant NDV Vectored Vaccine for SARS-CoV-2, Placebo)
Recruiting
- SARS CoV 2 Infection
- Recombinant NDV Vectored Vaccine for SARS-CoV-2
- Placebo
-
Mexico City, Cdmx, Mexico
- +3 more
Mar 23, 2022
Resilience in Pulmonary Arterial Hypertension and Genetically
Recruiting
- Idiopathic Pulmonary Arterial Hypertension
- +3 more
-
Nashville, TennesseeVanderbilt University Medical Center
Dec 9, 2022
Healthy, no Evidence of Disease Trial in Cleveland (IMPACT intervention, Online education materials, survey administration)
Completed
- Healthy, no Evidence of Disease
- IMPACT intervention
- +2 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Seidman Cancer Ce
Jul 20, 2020
Neurofilaments for NEDA Assessing in MS
Terminated
- Multiple Sclerosis
-
London, England, United KingdomQueen Mary University of London
Feb 9, 2022
No Evidence of Disease Trial in Buffalo (Clinical Observation, Flaxseed, Laboratory Biomarker Analysis)
Completed
- No Evidence of Disease
- Clinical Observation
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 6, 2022
Dysplastic Nevus, Health Status Unknown, Melanoma Trial in New Brunswick (Best Practice, mySmartCheck, Survey Administration)
Completed
- Dysplastic Nevus
- +3 more
- Best Practice
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 5, 2022
Healthy, no Evidence of Disease Trial in Buffalo (dietary supplement, other, biological)
Terminated
- Healthy, no Evidence of Disease
- cholecalciferol
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 2, 2020
Breast Cancer, Healthy, no Evidence of Disease Trial in Philadelphia (behavioral, other, procedure)
Completed
- Breast Cancer
- Healthy, no Evidence of Disease
- exercise intervention
- +12 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 15, 2020